FAQ: HeartBeam and HeartNexus Partnership for 24/7 Remote Cardiology Services
Summary
HeartBeam has partnered with HeartNexus to provide 24/7 remote cardiology services and real-time ECG interpretation using HeartBeam's patented 3D technology. This collaboration makes medical-grade cardiac monitoring accessible outside traditional medical facilities and expands HeartBeam's ecosystem with real-time cardiology feedback.
What is the main purpose of the HeartBeam and HeartNexus partnership?
The partnership enables HeartBeam to offer 24/7 cardiology reader services for patients experiencing cardiac symptoms outside traditional care settings, providing immediate ECG interpretation by board-certified cardiologists.
How does the HeartBeam technology work for patients?
Patients can capture a 30-second, cable-free ECG recording anytime symptoms occur using HeartBeam’s patented 3D technology, then transmit the data to HeartNexus cardiologists for immediate interpretation.
Why is this partnership significant for cardiac care?
It makes medical-grade cardiac monitoring accessible beyond the walls of medical facilities and accelerates HeartBeam’s mission to transform cardiac care through personalized insights and real-time feedback.
Who are the key companies and individuals involved in this partnership?
HeartBeam (NASDAQ: BEAT), a medical technology company, is partnering with HeartNexus Inc., a network of board-certified cardiologists, with Robert Eno serving as CEO of HeartBeam.
What is unique about HeartBeam’s 3D ECG technology?
HeartBeam’s technology is the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing the signals into a 12-lead ECG, designed for portable use wherever the patient is located.
What regulatory approvals does HeartBeam’s technology have?
HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, while the 12-Lead ECG synthesis software is currently under FDA review.
What future developments are planned for this partnership?
The partnership expands HeartBeam’s ecosystem with real-time cardiology feedback and includes future integration of AI wellness and wearable features.
Where can patients use this cardiac monitoring service?
The service is designed to be used wherever the patient is located, outside of traditional medical facilities, enabling cardiac monitoring in any location when symptoms occur.
What intellectual property does HeartBeam hold for this technology?
HeartBeam holds over 20 issued patents related to technology enablement for their 3D ECG platform technology.
Where can I find more information about HeartBeam and this partnership?
The full press release is available at https://ibn.fm/HqwuQ, and the latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at NewMediaWire
Article Control ID: 267727